Pituitary Adenoma Clinical Trials

14 recruiting

Frequently Asked Questions

Common questions about Pituitary Adenoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting
Not Applicable

DDAVP for Pituitary Adenoma

Pituitary AdenomaCushing's Disease
National Institute of Neurological Disorders and Stroke (NINDS)22 enrolled1 locationNCT04569591
Recruiting
Phase 1

Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas

Pituitary Adenoma
Mayo Clinic5 enrolled1 locationNCT07456878
Recruiting

Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors

Pituitary AdenomaCushing Disease
Mayo Clinic110 enrolled1 locationNCT07335315
Recruiting
Not Applicable

Molecular Pituitary Imaging Using 18F-FET PET

Pituitary Adenoma
University of Cambridge20 enrolled1 locationNCT06584123
Recruiting
Not Applicable

Effect of Foot Bath on Anxiety and Physiological Parameters

SurgeryPituitary Adenoma
Trakya University100 enrolled1 locationNCT07247526
Recruiting
Phase 4

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

ParagangliomaMeningiomaEsthesioneuroblastoma+4 more
Weill Medical College of Cornell University200 enrolled1 locationNCT04081701
Recruiting
Not Applicable

Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors

MeningiomaDiffuse GliomaPituitary Adenoma+2 more
Tata Memorial Centre156 enrolled1 locationNCT06831461
Recruiting

Effects of Pasireotide Lar Therapy on Bone Metabolism

Acromegaly Due to Pituitary AdenomaAcromegaly
Fondazione Policlinico Universitario Agostino Gemelli IRCCS120 enrolled1 locationNCT07179926
Recruiting

Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA

Familial Isolated Pituitary AdenomaAcromegalyGigantism+3 more
Barts & The London NHS Trust10,000 enrolled3 locationsNCT00461188
Recruiting

A Twenty-years' Experience in Pituitary Disease.

Pituitary CancerPituitary AdenomaPituitary Disease
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1,600 enrolled1 locationNCT06973824
Recruiting
Not Applicable

KETOgenic Diet Therapy in Patients With ACROmegaly

Acromegaly Due to Pituitary AdenomaKetogenic DietMediterranean Diet
Erasmus Medical Center60 enrolled1 locationNCT06949891
Recruiting

The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction

MeningiomaPituitary AdenomaCraniopharyngioma+3 more
Universitaire Ziekenhuizen KU Leuven154 enrolled3 locationsNCT06874426
Recruiting
Phase 4

Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors

Pituitary AdenomaPituitary Neuroendocrine Tumor
Beijing Tiantan Hospital882 enrolled1 locationNCT06679816
Recruiting

SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)

MeningiomaSchwannomaBrain Tumor, Primary+2 more
Seoul National University Hospital3,000 enrolled1 locationNCT05254197
Recruiting

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Neuroendocrine NeoplasmParagangliomaPheochromocytoma+23 more
Universidad Nacional Autonoma de Mexico750 enrolled3 locationsNCT06523582
Recruiting
Not Applicable

Neurocognition After Radiotherapy in CNS- and Skull-base Tumors

Brain TumorMeningiomaMagnetic Resonance Imaging+3 more
Universitaire Ziekenhuizen KU Leuven120 enrolled3 locationsNCT05727605
Recruiting

Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors

Neuroendocrine TumorsPituitary Adenoma
Sun Yat-sen University300 enrolled1 locationNCT06015802
Recruiting
Phase 4

Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions

Pituitary AdenomaAntibiotics
St. Joseph's Hospital and Medical Center, Phoenix116 enrolled1 locationNCT03014687